A bibliometric analysis of the cannabis and cannabinoid research literature

[31] Nagel BJ(2018)A bibliometric analysis of Cannabis publications: six decades of research and a gap on studies with the plant Publications. 6 40-252

[32] Corey-Bloom J(2005)Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response J Immunol 174 3281-228

[33] Wolfson T(2010)Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies Int J Drug Policy 21 10-1131

[34] Gamst A(2010)An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results Drug Alcohol Rev 29 304-331

[35] Jin S(2007)Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 319-451

[36] Marcotte TD(2012)Quantifying cannabis use with the timeline followback approach: a psychometric evaluation Drug Alcohol Depend 121 247-1887

[37] Bentley H(2012)A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex®(nabiximols) Mult Scler J 18 219-1417

[38] Crippa JA(2011)A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols*(Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis Eur J Neurol 18 1122-8351

[39] Zuardi AW(2017)The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review Ann Intern Med 167 319-306

[40] Martín-Santos R(2018)Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents Am J Drug Alcohol Abuse 44 441-349

[31] Nagel BJ(2018)A bibliometric analysis of Cannabis publications: six decades of research and a gap on studies with the plant Publications. 6 40-252

[32] Corey-Bloom J(2005)Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response J Immunol 174 3281-228

[33] Wolfson T(2010)Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies Int J Drug Policy 21 10-1131

[34] Gamst A(2010)An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results Drug Alcohol Rev 29 304-331

[35] Jin S(2007)Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 319-451

[36] Marcotte TD(2012)Quantifying cannabis use with the timeline followback approach: a psychometric evaluation Drug Alcohol Depend 121 247-1887

[37] Bentley H(2012)A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex®(nabiximols) Mult Scler J 18 219-1417

[38] Crippa JA(2011)A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols*(Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis Eur J Neurol 18 1122-8351

[39] Zuardi AW(2017)The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review Ann Intern Med 167 319-306

[40] Martín-Santos R(2018)Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents Am J Drug Alcohol Abuse 44 441-349